Maci

Vericel has received FDA approval to expand its MACI label to include MACI Arthro, an arthroscopic delivery of MACI to repair symptomatic knee cartilage defects, according to a company press release.

Although cartilage repair and restoration still pose clinical challenges in orthopedics, the knowledge of cartilage repair and healing gained in the last decade has resulted in advanced surgical techniques and improved outcomes.

Logistical considerations surrounding COVID-19 testing have become part of the weekly routine of orthopedic surgeons.

Arthroscopic matrix-assisted autologous chondrocyte transplantation for articular cartilage defects of the knee may offer positive, long-lasting results with limited failures or reinterventions, according to published results.